Understanding adverse drug reactions

Adverse Drug Reactions (ADRs) are unintended and harmful effects that occur when a medicine is taken at normal, prescribed doses. They are not overdoses or medication errors, but rather side effects that happen even when a drug is used correctly. ADRs can range from mild issues like nausea or fatigue to serious complications such as organ toxicity, severe allergic reactions, cardiac effects, or hospitalisation.

Addressing ADRs is critically important in healthcare because they are one of the leading causes of treatment discontinuation, emergency visits, and hospital readmissions. They also significantly increase healthcare costs and can lead to a loss of patient trust in therapy. For chronic conditions like CNS disorders, even moderate side effects can lead to missed doses and relapse. In oncology or critical care, severe ADRs can delay life-saving treatment or require intensive monitoring. A medicine may be effective, but if patients cannot tolerate it, it cannot deliver its full benefit.

How tatva pharma addresses ADRs

Tatva Pharma reduces adverse drug reactions by redesigning how medicines are delivered, without altering the active molecule itself. Our focus is on creating smoother release profiles to reduce peak-related toxicity, optimising excipients to minimise irritation, and designing lower-volume, ready-to-use injectables that improve tolerability and consistency. When drug exposure is more stable and delivery is simpler, side effects decrease, and patient outcomes improve.

What exactly are 'adverse drug reactions' (ADRs) and why is it so important for healthcare to address them?

ADRs are unintended and harmful effects that occur when a medicine is taken at normal, prescribed doses. They are not overdoses or medication errors, but side effects that happen even when a drug is used correctly. They can range from mild (nausea, fatigue, injection-site pain) to serious (organ toxicity, allergic reactions, cardiac effects, hospitalisation).

Addressing ADRs is crucial because they are a leading cause of treatment discontinuation, emergency visits, hospital readmissions, increased healthcare costs, and loss of patient trust. In chronic conditions, moderate side effects can lead to missed doses and relapse. In critical care, severe ADRs can delay life-saving treatment. If a medicine cannot be tolerated, its full benefit cannot be delivered.

How does tatva pharma specifically improve existing injectable medicines to reduce these ADRs?

Tatva Pharma reduces adverse drug reactions by redesigning how medicines are delivered, not by changing the molecule itself. We create smoother release profiles to reduce peak-related toxicity, optimise excipients to minimise irritation, and design lower-volume, ready-to-use injectables that improve tolerability and consistency. When drug exposure is more stable and delivery is simpler, side effects decrease — and outcomes improve.

Who stands to benefit most from tatva pharma's work in making medicines safer, and what are those key benefits?

Patients benefit most:

  • Fewer side effects from smoother drug release
  • Less injection pain and irritation
  • Fewer hospital visits with long-acting formats
  • Better adherence and more stable disease control

Clinicians and hospitals also gain:

  • Reduced monitoring burden from peak-related toxicity
  • Fewer treatment interruptions
  • Lower risk of administration-related complications

Healthcare systems benefit at scale:

  • Fewer readmissions
  • Lower total cost of care
  • More efficient use of clinical capacity

In essence: Safer delivery means better tolerance, better adherence, and better outcomes for everyone involved.

Driving safer medicine, together

At Tatva Pharma, our journey is to redefine the standard of care by making established injectable medicines safer and more effective. We believe that by optimising drug release and delivery, we can significantly reduce the burden of adverse drug reactions on patients, clinicians, and healthcare systems. Join us in our mission to enhance patient outcomes and improve the efficiency of healthcare worldwide.